Form 8-K - Current report:
SEC Accession No. 0001104659-25-049007
Filing Date
2025-05-15
Accepted
2025-05-15 08:09:22
Documents
15
Period of Report
2025-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515183d1_8k.htm   iXBRL 8-K 26654
2 EXHIBIT 4.1 tm2515183d1_ex4-1.htm EX-4.1 93813
3 EXHIBIT 10.1 tm2515183d1_ex10-1.htm EX-10.1 47012
  Complete submission text file 0001104659-25-049007.txt   374865

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA trvn-20250514.xsd EX-101.SCH 3020
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20250514_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20250514_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2515183d1_8k_htm.xml XML 3339
Mailing Address 2870 PEACHTREE ROAD SUITE 502 ATLANTA GA 30305
Business Address 2870 PEACHTREE ROAD SUITE 502 ATLANTA GA 30305 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 261469215 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 25948837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)